Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
LongArm Engineering to implement Safe Entry fitted with Fit for Duty Screening at Odessa Texas facility and new Corporate Office
Long Arm Engineering將在德克薩斯州敖德薩工廠和新公司辦公室實施適合值班篩查的安全進入
TORONTO, ON / ACCESSWIRE / November 17, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the revenue-generating deployment of Safe Entry to be deployed at LongArm Engineering's Odessa Texas facility, secured by the Company's lead reseller, SBL Testing Technologies.
多倫多，on/ACCESSWIRE/2022年11月17日/由專有人工智能(AI)支持的快速健康篩查解決方案的新興提供商Predicmedix Inc.(CSE：PMED)(場外交易市場代碼：PMEDF)(以下簡稱“Predidicmedix”或“公司”)今天宣佈，將在Long Arm Engineering的德克薩斯州敖德薩工廠部署安全進入系統，該系統將由該公司的主要經銷商SBL Testing Technologies擔保。
LongArm Engineering will be implementing Safe Entry at their Odessa Texas facility, a full cycle operation including engineering, electrical, automation, and fabrication. Odessa Texas is in the heart of the Permian Basin, currently one of the largest and most active oil & gas basin hotspots. Safe Entry will be used to screen staff, contractors, clients, and guests to ensure a healthy and safe workplace.
Long Arm Engineering將在其德克薩斯州敖德薩工廠實施安全進入，這是一個包括工程、電氣、自動化和製造在內的全週期運營。德克薩斯州敖德薩位於二疊紀盆地的中心，目前是最大和最活躍的油氣盆地熱點之一。安全進入將用於對工作人員、承包商、客户和客人進行篩選，以確保工作場所的健康和安全。
"We see Safe Entry as a tool to maintain a safe workplace amongst our employees, contractors, and clients as they enter our facility. This will ensure prevention of spread of any infectious disease to others and keep our company strong. Our employees are critical to our business and see this as a commitment to their health. Alcohol and Cannabis screening will show we are dedicated to performing our services in a professional environment," said Aaron Young, Managing Partner of LongArm Engineering.
Long Arm Engineering管理合夥人Aaron Young表示：“我們將安全入境視為員工、承包商和客户進入我們工廠時維護安全工作場所的一種工具。這將確保防止任何傳染病傳播給其他人，並保持我們公司的強大。我們的員工對我們的業務至關重要，並將此視為對他們健康的承諾。酒精和大麻篩查將表明我們致力於在專業環境中提供服務，”Long Arm Engineering的管理合夥人Aaron Young表示。
"We are seeing increasing demand for Safe Entry. Businesses and organizations in all market verticals are strengthening their pandemic response strategies. Safe Entry is very differentiated and unique in detecting multiple symptoms of infectious diseases, all on a continuously learning AI platform. It's a key technology within long-term strategies." stated Rich Rollibard from SBL Testing Technologies.
我們看到對安全進入的需求越來越大。所有垂直市場的企業和組織都在加強他們的流行病應對戰略。安全進入在檢測傳染病的多種症狀方面非常差異化和獨特，所有這些都是在一個持續學習的人工智能平臺上。這是長期戰略中的一項關鍵技術。來自SBL測試技術公司的Rich Rollibard説。
"The global interest in supplying Safe Entry is also increasing. SBL is on-boarding partner companies to supply and support Safe Entry in all regions of the world." Robillard added. "The evolution of Safe Entry technology has been eye opening, and now being able to screen for not only infectious diseases but simultaneously alcohol and cannabis use, is a huge feat. We are excited to see the positive impact it will have on LongArm Engineering's workforce," said Dr. Rahul Kushwah, Interim CEO at Predictmedix.
全球對提供安全入境的興趣也在增加。SBL正在與合作伙伴公司合作，在世界所有地區提供和支持安全入境。羅比拉德補充道。Predidicmedix公司臨時首席執行官拉胡爾·庫什瓦博士表示：“安全進入技術的發展令人大開眼界，現在不僅能夠篩查傳染病，還能同時篩查酒精和大麻的使用，這是一項巨大的壯舉。我們很高興看到它將對長臂工程公司的員工隊伍產生積極影響。”
About LongArm Engineering
LongArm Engineering is one of the Permian Basins' fastest growing full-service automation and electrical firms, with services ranging from well site servicing to major construction projects. To learn more about LongArm Engineering, please click here.
關於長臂工程
Long Arm Engineering是二疊紀盆地增長最快的全方位自動化和電氣公司之一，服務範圍從油井現場服務到重大建設項目。要了解更多有關長臂工程的信息，請單擊此處。
About SBL Testing Technologies Inc.
SBL integrates innovative safety & testing technologies into complex workplaces, aligning to corporate risk profiles, safety programs and operational processes. SBL works with businesses, government agencies, and organizations in all industrial sectors globally, leveraging technology to reduce risk and enhance policy effectiveness. SBL's team has successfully provided risk management, safety solutions and testing technologies for decades, working with leading technology manufacturers from around the globe. SBL's Pandemic Response / Business Continuity solutions are led by a team who have successfully delivered fully integrated solutions to government agencies & Fortune 500 companies worldwide. For more information visit us online at
關於SBL測試技術公司
SBL將創新的安全和測試技術集成到複雜的工作場所，與企業風險概況、安全計劃和運營流程保持一致。SBL與全球所有工業部門的企業、政府機構和組織合作，利用技術降低風險並提高政策有效性。幾十年來，SBL的團隊與全球領先的技術製造商合作，成功地提供了風險管理、安全解決方案和測試技術。SBL的大流行應對/業務連續性解決方案由一支成功地向全球政府機構和財富500強公司提供全面集成解決方案的團隊領導。欲瞭解更多信息，請訪問我們的在線網站
About Predictmedix Inc.
Predictmedix (CSE:PMED) (OTCQB:PMEDF) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatique or various mental illnesses. Predictmedix's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at or follow us on Twitter, Instagram or LinkedIn.
關於Predicate Medix Inc.
普瑞醫療(CSE：PMED)(場外市場代碼：PMEDF)是一家新興的全球快速健康篩查和遠程患者護理解決方案提供商。該公司的安全入口站由專有人工智能(AI)提供支持，使用多光譜相機分析生理數據模式並預測各種健康問題，包括傳染病(如新冠肺炎)、藥物或酒精損害、疲勞或各種精神疾病。PredidicMedix專有的遠程患者護理平臺為醫療專業人員提供了一套人工智能支持的工具，以改善患者的健康狀況。要了解更多信息，請訪問我們的網站，或在Twitter、Instagram或LinkedIn上關注我們。
Investor Relations Contact
Corey Matthews
Investors@predictmedix.com
投資者關係聯繫人
科裏·馬修斯
郵箱：Investors@forectmedix.com
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any Page 4 of 4 future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.
有關前瞻性信息的警告：
本新聞稿可能包含基於當前預期的前瞻性陳述和信息。這些聲明不應被解讀為對公司未來業績或結果的保證。這類陳述涉及已知和未知的風險、不確定因素和其他因素，可能導致實際結果、業績或成就與這類陳述所暗示的大不相同。雖然這些陳述是基於管理層的合理假設，但不能保證這些假設將被證明是正確的。我們不承擔更新或修改它們以反映新事件或新情況的責任。本公司的證券尚未根據修訂後的《1933年美國證券法》(下稱《美國證券法》)或適用的州證券法進行註冊，除非進行註冊或獲得適用的豁免，否則不得向美國境內的人或美國人提供或出售，或為美國境內的人或“美國人”的賬户或為他們的利益服務。本新聞稿不應構成出售要約或徵求購買要約，也不應在美國或任何司法管轄區出售任何此類要約、徵求或出售將是非法的證券。此外，存在已知和未知的風險因素，可能導致公司的實際結果、業績或成就與本文中包含的前瞻性信息明示或暗示的未來結果、業績或成就的第4頁存在實質性差異，例如但不限於對獲得監管部門批准的依賴；獲得與其技術相關的知識產權的能力；有限的經營歷史；一般商業、經濟、競爭、政治、監管和社會方面的不確定性，尤其是, 與新冠肺炎有關的不確定性；與公司無法控制的因素有關的風險，包括與新冠肺炎有關的風險；與公司股票有關的風險，包括因可能或可能不在公司控制範圍內的事件而引起的價格波動；對管理層的依賴；以及行業中更多競爭對手的緊急情況。
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
本文中的所有前瞻性信息都受本警示聲明的約束，公司沒有義務修改或更新任何此類前瞻性信息，也沒有義務公開宣佈對本文中包含的任何前瞻性信息的任何修改結果，以反映未來的結果、事件或發展，除非法律要求。
Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time."
免責聲明：“本公司目前不會明示或暗示其產品有能力診斷、消除、治癒或控制新冠肺炎(或SARS-2冠狀病毒)。”
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
加拿大證券交易所尚未對本新聞稿的充分性或準確性進行審查，也不承擔任何責任。
SOURCE: PredictMedix Inc.
資料來源：PredidicMedex Inc.
譯文內容由第三人軟體翻譯。